… The correct identification of patients at increased risk of non-… of non-alcoholic fatty liver disease
(NAFLD). Since liver … and affordable alternatives for identification of patients at high risk of …

… of non-invasive tests (NITs) as an alternative to biopsy for diagnosis of advanced fibrosis and
determination … methodologies for a heterogenous disease state such as NAFLD has been …

… non-invasive liver fibrosis assessment using transient elastography. In an individual data
meta-analysis, … in 2,735 patients with mixed liver disease aetiologies (mainly viral hepatitis and …

… disease in the United States, affecting approximately 1 out of every 4 Americans. NAFLD is
a spectrum of disorders … A pooled meta-analysis of 11 studies and over 800 patients showed …

… , hepatic, malignant, and musculoskeletal disease states. The need for a more specific …
value ratio of median disease over the median control of detection in serum and saliva were …

… all individuals with chronic liver disease as it predicts the risk of future liver-related morbidity
and thus need for treatment, monitoring and surveillance. Non-invasive fibrosis tests (NITs) …

… which are used for non-invasive medical diagnosis and … classroom course on Non-Invasive
Medical Instrumentation … biophysicists interested in learning state of the art techniques …

… the progression of chronic liver disease, determine prognosis, establish optimal timing …
disease states. In the remainder of this evaluation, we review the recent literature of non-invasive …

… In 1983, Chorzelski and co-workers first used the EMA test which was the first non-invasive
test for CD diagnosis.15 In 1997, Dieterich and colleagues defined tTG antigen, which is the …

… For example, blood sugar is used to determine the diabetic state of a person [20,21],
prostate-specific antigen (PSA) is used for prostate cancer screening [22], etc. However, these …